Inventaire - your friends and communities are your best library - Inventaire

Amyloid-PET and 18F-FDG-PET in the diagnostic investigation of Alzheimer's disease and other dementias

author

Philip Scheltens

Frederik Barkhof

Clifford Jack

Victor L Villemagne

David J. Brooks

Adriaan A Lammertsma

Maria C Carrillo

Giovanni B. Frisoni

Henryk Barthel

Gaël Chételat

Rik Ossenkoppele

Gil D Rabinovici

Karl Herholz

Oskar Hansson

Agneta Nordberg

Alexander Drzezga

Wim Oyen

published in: Lancet Neurology

date of publication: 2020-11-01

Cites articles 93

Date

Title

Authors

2020-04-06

Biomarkers for Alzheimer's disease-preparing for a new era of disease-modifying therapies

Henrik Zetterberg
2019-06

Clinical impact of [F]flutemetamol PET among memory clinic patients with an unclear diagnosis

Agneta Nordberg
2019-08-06

Incremental value of amyloid-PET versus CSF in the diagnosis of Alzheimer's disease

Matteo Cotta Ramusino, Valentina Garibotto, Ruggero Bacchin, Alfredo Costa, Matteo Bauckneht, Davide V. Moretti
2019-10-18

Predictive Value of 18F-Florbetapir and 18F-FDG PET for Conversion from Mild Cognitive Impairment to Alzheimer Dementia

Lars Frings, Alzheimer's Disease Neuroimaging Initiative, David Eidelberg, Ganna Blazhenets, Arnd Sörensen
2019-05-24

Predicting long-term clinical stability in amyloid-positive subjects by FDG-PET

Leonardo Iaccarino, Arianna Sala, Alzheimer's Disease Neuroimaging Initiative
2019-04-01

Association of Amyloid Positron Emission Tomography With Subsequent Change in Clinical Management Among Medicare Beneficiaries With Mild Cognitive Impairment or Dementia

Ilana F Gareen, Rachel Whitmer
2018-04-01

NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease.

Philip Scheltens, Reisa Sperling, David M. Holtzman, Kaj Blennow, William J. Jagust, Maria C Carrillo, Clifford Jack, Jason Karlawish, Katherine P Rankin, Frank Jessen, Christopher C Rowe, Thomas J Montine, Creighton H Phelps, Heather M Snyder, Eric R Siemers
2018-07-18

Molecular imaging in dementia: Past, present, and future

Robert Laforce
2018-12-01

Current state of Alzheimer's fluid biomarkers

Philip Scheltens, Michelle M Mielke, Harald Hampel, Henrik Zetterberg, Kaj Blennow, Anne M Fagan, Jeffrey L. Cummings, John Q. Trojanowski
2018-08-19

Biomarkers for Alzheimer's disease: current status and prospects for the future

K Blennow
2018-01-01

Dual Time-Point [18F]Florbetaben PET Delivers Dual Biomarker Information in Mild Cognitive Impairment and Alzheimer's Disease

Dorothee Saur, Arno Villringer
2018-08-31

Neurofilaments as biomarkers in neurological disorders

Markus Otto, Franz Fazekas, Michael Khalil, Henrik Zetterberg, Kaj Blennow, Ludwig Kappos, Charlotte Teunissen, Manuel Comabella Lopez, Christian Barro, Jens Kuhle, Thomas Gattringer
2018-01-28

FDG-PET and CSF biomarker accuracy in prediction of conversion to different dementias in a large multicentre MCI cohort.

Tommaso Ballarini, Luca Presotto, Sandro Iannaccone
2018-04-27

Clinical utility of FDG-PET for the clinical diagnosis in MCI.

Javier Arbizu, Federica Agosta, Cristina Festari, Stefania Orini, Peter J Nestor, Flavio Nobili
2018-07-20

European Association of Nuclear Medicine and European Academy of Neurology recommendations for the use of brain 18 F-fluorodeoxyglucose positron emission tomography in neurodegenerative cognitive impairment and dementia: Delphi consensus

Peter J Nestor
2018-01-01

18F-FDG PET for Prediction of Conversion to Alzheimer's Disease Dementia in People with Mild Cognitive Impairment: An Updated Systematic Review of Test Accuracy

Louise Lafortune, Carol Brayne, Sarah Kelly
2018-11-01

Prevalence of amyloid-β pathology in distinct variants of primary progressive aphasia

Miguel A Santos-Santos, Wiesje van der Flier, Jason D. Warren, Oriol Grau-Rivera, Cristian E. Leyton, Olivier Piguet, Eloi Magnin, Florence Pasquier, Niklas Mattsson, Oskar Hansson, Julien Dumurgier, Lars Frings, Janine Diehl-Schmid, Kristian S Frederiksen, Robert Laforce, Yolande A L Pijnenburg, Sandra Black, Philip Scheltens, John Hodges, Rik Vandenberghe, Raquel Sanchez-Valle, Mario F Mendez, William Seeley, Bruce L. Miller, Jonathan D Rohrer, Nick C. Fox, John Van Swieten, Ging-Yuek R Hsiung, Julie Snowden, Victor L Villemagne, Harro Seelaar, Mario Masellis, Christopher C Rowe, Bradford C Dickerson, Jonathan M Schott, Janne M Papma, Pascual Sánchez-Juan, Bart N M van Berckel, Timo Grimmer, Willemijn J Jansen, Pieter Jelle Visser, Marie Sarazin, David Wolk, Gaël Chételat, Rik Ossenkoppele, Gil D Rabinovici, Alberto Lleó, Claire Paquet, M Antoinette Keulen, David Bergeron, Patricio Chrem-Mendez, Marc Teichmann, M-Marsel Mesulam, Sang Won Seo
2018-01-01

A Systematic Review and Aggregated Analysis on the Impact of Amyloid PET Brain Imaging on the Diagnosis, Diagnostic Confidence, and Management of Patients being Evaluated for Alzheimer's Disease

Alexander Hammers, John T. O'Brien
2018-09-01

Association of Amyloid Positron Emission Tomography With Changes in Diagnosis and Patient Treatment in an Unselected Memory Clinic Cohort: The ABIDE Project

Wiesje Pelkmans, Arno de Wilde, Wiesje van der Flier, Philip Scheltens, Frederik Barkhof, Rik Ossenkoppele, Marleen Kunneman, Adriaan A Lammertsma, Femke Bouwman, Bart N M van Berckel, Marissa D Zwan, Ellen M A Smets, Marieke M van Buchem
2018-04-18

Quantitative appraisal of the Amyloid Imaging Taskforce appropriate use criteria for amyloid-PET.

Cristina Festari
2018-12-13

Subjective cognitive decline and rates of incident Alzheimer's disease and non-Alzheimer's disease dementia

Efthimios Dardiotis, Tobias Luck, Barry Reisberg, Susanne Roehr, Perminder Sachdev, Sander C J Verfaillie, Shannon L. Risacher, Alzheimer's Disease Neuroimaging Initiative, Nikolaos Scarmeas, Philip Scheltens, Steffen Wolfsgruber, Frank Jessen, Pieter Jelle Visser, Harald Hampel, Paul Maruff, Michael Wagner, Steffi G. Riedel-Heller, Wiesje van der Flier, Rachel F Buckley, Andrew J. Saykin, Stephanie De Vos, Sietske Sikkes, Rosalinde E R Slot, Enrica Cavedo, José Luis Molinuevo
2018-10-16

AMYPAD Diagnostic and Patient Management Study: Rationale and design

Valentina Garibotto, Agneta Nordberg, Pierre Payoux, Miia Kivipelto, Philip Scheltens, Frank Jessen, Alexander Drzezga
2018-03-01

Rates of Amyloid Imaging Positivity in Patients With Primary Progressive Aphasia.

Edoardo G. Spinelli, Maria Luisa Gorno-Tempini, Bruce L. Miller, Maria Luisa Mandelli, William Seeley, Gil D Rabinovici, Nagehan Ayakta, William J. Jagust, Lea T Grinberg, Howard J Rosen, Miguel A Santos-Santos, Pia M Ghosh, Iryna Lobach, Christa Watson, Gautam Tammewar, Andreas Lazaris
2018-05-09

Diagnostic utility of FDG-PET in the differential diagnosis between different forms of primary progressive aphasia

Femke Bouwman, Stefania Orini, Cristina Festari, Federica Agosta, Javier Arbizu, Peter J Nestor
2018-05-19

Clinical utility of FDG PET in Parkinson's disease and atypical parkinsonism associated with dementia

Zuzana Walker, Stefania Orini, Valentina Garibotto, Federica Agosta, Javier Arbizu, Peter J Nestor, Cristina Festari, Alexander Drzezga
2018-01-31

Spatial patterns of neuroimaging biomarker change in individuals from families with autosomal dominant Alzheimer's disease: a longitudinal study.

Marcus E. Raichle, Johannes Levin, Peter R Schofield, David M. Holtzman, Martin Rossor, Anne M Fagan, Colin L. Masters, Clifford Jack, Daniel S. Marcus, Tammie L. Benzinger, John C. Morris, Randall J. Bateman, Beau M. Ances, Nigel J Cairns, Paul M. Thompson, Tyler Blazey, Russ C Hornbeck, David M. Cash, Adam M Brickman, Andrew J. Saykin, Neill R Graff-Radford, Nick C. Fox, Michael W. Weiner, Brian A Gordon, Eric McDade, Jason Hassenstab, Sarah B Berman, Stephen Salloway, Jasmeer Chhatwal, Katrina L Paumier, Guoqiao Wang, Aylin Dincer, Shaney Flores, Amrita Hari-Raj, Christian la Fougère, Stephen Correia
2018-01-01

Impact of Amyloid PET Imaging in the Memory Clinic: A Systematic Review and Meta-Analysis

Steven T Dekosky
2018-06-09

Will biomarker-based diagnosis of Alzheimer's disease maximize scientific progress? Evaluating proposed diagnostic criteria

M. Maria Glymour, Mika Kivimäki, Geneviève Chêne, Carole Dufouil
2018-10-22

Questions concerning the role of amyloid-β in the definition, aetiology and diagnosis of Alzheimer's disease

Bryce Vissel
2018-01-01

The Vascular Hypothesis of Alzheimer's Disease: A Key to Preclinical Prediction of Dementia Using Neuroimaging
2017-07-11

Strategic roadmap for an early diagnosis of Alzheimer's disease based on biomarkers

Bruno Dubois, Corinna Porteri, Karl-Olof Lovblad, Panteleimon Giannakopoulos, Anton F Gietl, Valentina Gallo, Jean-Francois Démonet, Oskar Hansson, Flavio Nobili, Philip Scheltens, Ida Sonni, Kaj Blennow, Stefan J Teipel, Paolo Vineis, Bengt Winblad, Frederik Barkhof, Maria C Carrillo, Clifford Jack, Agneta Nordberg, Niklas Mattsson, Emiliano Albanese, Patrick Bossuyt, José Luis Molinuevo, Giovanni B. Frisoni, Jonathan M Schott, Pieter Jelle Visser, Mara Ten Kate, Karl Herholz, Karl-Olof Lovblad, Stefano Cappa, Heather M Snyder, Agnese Picco, Ezio Giacobini
2017-06-07

Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium

Zuzana Walker, Jose Bras, Jon B. Toledo, James B Leverenz, Howard Feldman, David Burn, Dag Aarsland, Glenda Halliday, Clive Ballard, John Q. Trojanowski, Eliezer Masliah, Sam Brundin, Nicolaas I Bohnen, Owen A. Ross, Simon J.G. Lewis, Brit Mollenhauer, Andrew Singleton, Walter A. Kukull, Thomas G Beach, Kejal Kantarci, John-Paul Taylor, Ian G. McKeith, Bradley F Boeve, Neill R Graff-Radford, Alan J. Thomas, Jennifer G Goldman, Johannes Attems, Tanis J Ferman, Stephen N Gomperts, Lawrence S Honig, John T. O'Brien, Ronald B Postuma, James E Galvin, D Galasko, Mario Masellis, Debby W Tsuang, Thomas J Montine, Dennis W. Dickson, Alice S Chen-Plotkin, Daniel I Kaufer, Carol F Lippa, Melissa E. Murray, Pietro Tiraboschi

Article - wd:Q100960870

Welcome to Inventaire

the library of your friends and communities

you are offline